| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.56B | 51.52B | 44.55B | 40.98B | 41.95B | 41.68B |
| Gross Profit | 36.58B | 41.27B | 34.77B | 32.43B | 33.17B | 31.88B |
| EBITDA | 21.73B | 25.43B | 20.61B | 19.63B | 21.27B | 19.19B |
| Net Income | 13.05B | 15.09B | 12.33B | 11.64B | 13.40B | 12.16B |
Balance Sheet | ||||||
| Total Assets | 127.76B | 136.41B | 121.05B | 109.11B | 99.47B | 86.23B |
| Cash, Cash Equivalents and Short-Term Investments | 105.53B | 114.90B | 100.57B | 89.85B | 80.14B | 67.15B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 19.50B | 17.72B | 16.02B | 15.10B | 15.79B | 14.93B |
| Stockholders Equity | 108.25B | 118.69B | 105.03B | 94.00B | 83.68B | 71.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 19.11B | 14.98B | 13.03B | 16.80B | 14.06B |
| Operating Cash Flow | 0.00 | 19.63B | 15.02B | 13.05B | 16.80B | 14.08B |
| Investing Cash Flow | 0.00 | -13.85B | -27.13B | -8.56B | -3.85B | -2.02B |
| Financing Cash Flow | 0.00 | -1.54B | -1.28B | -1.28B | -1.03B | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥35.62B | 19.48 | ― | 1.74% | 8.98% | 12.22% | |
79 Outperform | ¥23.67B | 11.47 | ― | ― | 13.54% | 54.38% | |
77 Outperform | ¥243.41B | 14.85 | ― | 0.43% | 15.63% | 22.43% | |
68 Neutral | ¥34.97B | 13.76 | ― | 0.39% | 22.45% | 23.34% | |
64 Neutral | ¥12.94B | 15.38 | ― | 0.91% | 23.90% | 167.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
45 Neutral | ¥112.54B | 32.36 | ― | 0.14% | 12.38% | -92.66% |